{"iri":"http://lmss.sali.org/1b1KZdAgRbWxsNMPwu4yyQ","id":"1b1KZdAgRbWxsNMPwu4yyQ","label":"Pharmaceutical Preparation Manufacturing","definition":"This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.","prefLabels":[],"altLabels":[],"examples":[],"notes":[],"sources":["https://www.naics.com/six-digit-naics/?code=325412"],"branch":{"iri":"http://lmss.sali.org/R8f4qGdjxuiQary8OBpq8W9","label":"Industry and Market"},"parents":[{"iri":"http://lmss.sali.org/D0mnTJCRQ0iGNX03-SnqlQ","id":"D0mnTJCRQ0iGNX03-SnqlQ","label":"Pharmaceutical and Medicine Manufacturing"}],"children":[],"relations":[],"url":"https://lmss.io/tag/1b1KZdAgRbWxsNMPwu4yyQ/","source":{"repo":"sali-legal/LMSS","ref":"3f9ac0c9357b2a971582ae79ede243511d47811d","channel":"pre-release"}}